Because cancer drugs can be so destructive on the body, scientists are always looking for unique delivery methods that increase precision and decrease damage. A recent Futurity article reported on the most recent strategy that involves tiny bubbles. Researchers used extracellular vesicles (EVs) to delivery enzyme-producing genes that activate prodrug therapy in breast cancer cells. Because EVs are compatible with the human body, employing them to deliver treatment could minimize the risk of undesired immune responses from other therapies.
Bubbles are the Newest Cancer Drug Vehicles
Researchers believe nano-sized bubbles could carry cancer treatments that target and kill tumor cells.
Sep 19, 2019
How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read MoreTest Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More